| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.08 |